Clinical efficacy and safety of secukinumab in patients with psoriasis and comorbidities: pooled analysis of 4 phase 3 clinical trials

Authors: Gottlieb, Alice B., Wu, Jashin J., Griffiths, Christopher E. M., Marfo, Kwaku, Muscianisi, Elisa, Meng, Xiangyi, Frueh, Jennifer, Lebwohl, Mark

Source: Journal of dermatological treatment. 33(3):1482-1490

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100152156023.0x000001&indx=1&recIds=ETOCvdc_100152156023.0x000001

Evaluation of treatment patterns, healthcare resource utilization and cost of illness for sickle cell disease in Ghana: a private medical insurance claims database study.

Authors: Marfo, Kwaku¹ (AUTHOR), Dei-Adomakoh, Yvonne^2,3 (AUTHOR), Segbefia, Catherine^2,3 (AUTHOR), Dwomoh, Duah³ (AUTHOR), Edgal, Adeline⁴ (AUTHOR), Ampah, Nancy⁵ (AUTHOR), Ramachandrachar, Badarinath Chickballapur⁶ (AUTHOR) BCRamachandrachar@ae.imshealth.com, Subramanyam, Kumaresan⁷ (AUTHOR), Natarajan, Ashok⁶ (AUTHOR), Egbujo, Olufolake⁸ (AUTHOR), Ataga, Kenneth I.⁹ (AUTHOR)

Source: BMC Health Services Research. 9/21/2023, Vol. 23 Issue 1, p1-14. 14p. 1 Diagram, 6 Charts, 1 Graph.

Subject Terms: *SICKLE cell anemia, *ECONOMIC aspects of diseases, *HEALTH insurance, *DATABASES, *INSURANCE claims

Geographic Terms: GHANA, SUB-Saharan Africa

Barriers and facilitators to community acceptability of integrating point-of-care testing to screen for sickle cell disease in children in primary healthcare settings in rural Upper East Region of Northern Ghana.

Authors: Chatio, Samuel T., Duah, Enyonam, Ababio, Lucy O., Lister, Nicola, Egbujo, Olufolake, Marfo, Kwaku, Aborigo, Raymond, Ansah, Patrick, Odame, Isaac

Source: PLoS ONE; 5/20/2024, Vol. 19 Issue 5, p1-17, 17p

Subject Terms: SICKLE cell anemia, MEDICAL screening, POINT-of-care testing, HEALTH facilities, EMPLOYEE attitudes, PREMATURE infants

Geographic Terms: GHANA, SUB-Saharan Africa

P191 Secukinumab demonstrates a consistent safety profile in patients with psoriasis, psoriatic arthritis and ankylosing spondylitis over long term: updated pooled safety analyses

Authors: McInnes, Iain B, Baraliakos, Xenofon, Deodhar, Atul, Gottlieb, Alice B, Lebwohl, Mark, Schreiber, Stefan, Marfo, Kwaku, Bao, Weibin, Richards, Hanno B, Pricop, Luminita, Shete, Abhijit, Safi, Jorge, Mease, Philip J

Source: Rheumatology. 60(1)

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100144645722.0x000001&indx=1&recIds=ETOCvdc_100144645722.0x000001

Pretransplant anti-HLA-Cw and anti-HLA-DP antibodies in sensitized patients

Authors: Ling, Min, Marfo, Kwaku, Masiakos, Peter, Aljanabi, Aws, Lindower, Joel, Glicklich, Daniel, Boccardo, Graciela de, Greenstein, Stuart, Chapochnick-Friedmann, Javier, Kayler, Liise, Kinkhabwala, Milan, Akalin, Enver

Source: In Human Immunology September 2012 73(9):879-883

Pretransplant Immunologic Risk Assessment of Kidney Transplant Recipients With Donor-Specific Anti–Human Leukocyte Antigen Antibodies

Authors: Marfo, Kwaku, Ajaimy, Maria, Colovai, Adriana, Kayler, Liise, Greenstein, Stuart, Lubetzky, Michelle, Gupta, Anjali, Kamal, Layla, de Boccardo, Graciela, Masiakos, Peter, Kinkhabwala, Milan, Akalin, Enver

Source: Transplantation. 98(10):1082-1088

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100050745794.0x000001&indx=1&recIds=ETOCvdc_100050745794.0x000001

Bridging the Access Gap for Comprehensive Sickle Cell Disease Management Across Sub-Saharan Africa: Learnings for Other Global Health Interventions?

Authors: Hegemann, Lutz, Narasimhan, Vas, Marfo, Kwaku, Kuma-Aboagye, Patrick, Ofori-Acquah, Solomon, Odame, Isaac

Source: Annals of Global Health; 2023, Vol. 89 Issue 1, p1-7, 7p

Subject Terms: SICKLE cell anemia treatment, HEALTH services accessibility, INTERPROFESSIONAL relations, PUBLIC sector, MEDICAL care, PRIVATE sector, WORLD health, INSTITUTIONAL cooperation, RESOURCE-limited settings, HEALTH care rationing, MEDICAL care costs

Geographic Terms: SUB-Saharan Africa

Safety Profile of Crizanlizumab 5.0 Mg/Kg in Sickle Cell Disease: Pooled Data from Clinical Trials

Authors: Kutlar, Abdullah, Joshi, Vikas, Brueckner, Andreas, Kanter, Julie, Liles, Darla K., Lincy, Jeremie, Manjare, Rahul, Adomakoh, Yvonne Dei, Heeney, Matthew M., de Montalembert, Mariane, Keefe, Deborah, Marfo, Kwaku, Ataga, Kenneth I.

Source: In Blood 2 November 2023 142 Supplement 1:1139-1139

Long-term Safety of Secukinumab Over Five Years in Patients with Moderate-to-severe Plaque Psoriasis, Psoriatic Arthritis and Ankylosing Spondylitis: Update on Integrated Pooled Clinical Trial and Post-marketing Surveillance Data.

Authors: GOTTLIEB, Alice B., DEODHAR, Atul, MCINNES, Iain B., BARALIAKOS, Xenofon, REICH, Kristian, SCHREIBER, Stefan, Weibin BAO, MARFO, Kwaku, RICHARDS, Hanno B., PRICOP, Luminita, SHETE, Abhijit, TRIVEDI, Vivek, KEEFE, Deborah, PAPAVASSILIS, Charis C., JAGIELLO, Piotr, PAPANASTASIOU, Philemon, MEASE, Philip J., LEBWOHL, Mark

Source: Acta Dermato-Venereologica; 2022, Vol. 102, p1-9, 9p

Subject Terms: ANKYLOSING spondylitis, PSORIATIC arthritis, LATENT tuberculosis, MAJOR adverse cardiovascular events, PSORIASIS, CLINICAL trials

Barriers and Facilitators to Community Acceptability of Integrating Point-of-Care Testing to Screen for Sickle Cell Disease in Children in Primary Healthcare Settings in Rural Northern Ghana

Authors: Chatio, Samuel T. ^*, Duah, Enyonam ^*, Ababio, Lucy O. ^*, Lister, Nicola ^*, Egbujo, Olufolake ^*, Marfo, Kwaku ^*, Aborigo, Raymond ^*, Ansah, Patrick ^*, Odame, Isaac

Source: In Blood 15 November 2022 140 Supplement 1:5018-5018

15353 Presence of psoriatic arthritis has no impact on the clinical efficacy and safety of secukinumab in patients with psoriasis: Pooled analysis of four phase 3 clinical trials

Authors: Gottlieb, Alice B., Armstrong, April W., Elewski, Boni Elizabeth, Merola, Joseph F., Gomez, Braulio, Meng, Xiangyi, Marfo, Kwaku, Lebwohl, Mark

Source: Journal of the American Academy of Dermatology. 83(6):AB148-AB148

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100118322193.0x000001&indx=1&recIds=ETOCvdc_100118322193.0x000001

Association of Secukinumab Treatment With Tuberculosis Reactivation in Patients With Psoriasis, Psoriatic Arthritis, or Ankylosing Spondylitis.

Authors: Elewski, Boni E., Baddley, John W., Deodhar, Atul A., Magrey, Marina, Rich, Phoebe A., Soriano, Enrique R., Soung, Jennifer, Bao, Weibin, Keininger, Dorothy, Marfo, Kwaku, Patekar, Manmath, Sharma, Abhishek, Shete, Abhijit, Lebwohl, Mark Gabriel

Source: JAMA Dermatology; Jan2021, Vol. 157 Issue 1, p43-51, 9p

Clinical and economic analysis of short-course versus standard-course antithymocyte globulin (rabbit) induction therapy in deceased-donor renal transplant recipients.

Authors: Marfo, Kwaku¹ kmarfo@montefiore.org, Akalin, Enver², Wang, Cuiling³, Lu, Amy⁴

Source: American Journal of Health-System Pharmacy. 12/1/2011, Vol. 68 Issue 23, p2276-2282. 7p. 3 Charts.

Subject Terms: *THERAPEUTIC use of monoclonal antibodies, *IMMUNOSUPPRESSIVE agents, *ANTIBIOTICS, *ANTILYMPHOCYTIC serum, *DOSE-effect relationship in pharmacology, *FISHER exact test, *GRAFT rejection, *KIDNEY transplantation, *LONGITUDINAL method, *PREVENTIVE medicine, *ORGAN donors, *HEALTH outcome assessment, *RABBITS, *REGRESSION analysis, *STATISTICS, *T cells, *LOGISTIC regression analysis, *DATA analysis, *TREATMENT effectiveness, *RETROSPECTIVE studies, *DESCRIPTIVE statistics, *THERAPEUTICS

Tacrolimus Pharmacokinetic and Pharmacogenomic Differences between Adults and Pediatric Solid Organ Transplant Recipients.

Authors: Marfo, Kwaku¹, Altshuler, Jerry², Lu, Amy¹ alu@montefiore.org

Source: Pharmaceutics. Sep2010, Vol. 2 Issue 3, p291-299. 9p.

Subject Terms: *TACROLIMUS, *IMMUNOSUPPRESSIVE agents, *MACROLIDE antibiotics, *PHARMACOKINETICS, *DRUG metabolism, *PHARMACOGENOMICS, *TRANSPLANTATION of organs, tissues, etc. in children, *CARRIER proteins, *PROTEIN binding

PB2512: SAFETY OF CRIZANLIZUMAB IN PATIENTS WITH SICKLE CELL DISEASE: INTEGRATED POST‐MARKETING SURVEILLANCE ANALYSIS.

Authors: Abboud, Miguel, Kanter, Julie, Marfo, Kwaku, Anthony, Charmaine, Lincy, Jeremie, Nassin, Michele, Joshi, Vikas, Brueckner, Andreas, Keefe, Deborah, Ataga, Kenneth I.

Source: HemaSphere; 2023 Supplement 3, Vol. 7, p1-2, 2p

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.